Ryo Suzuki
Niigata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
High FDG Uptake in the Non-cancerous Lung Predicts Immune-Related Adverse Events and Poor Prognosis in Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors.
Journal: Academic radiology
Published: February 09, 2026
Nintedanib enhances the antitumor efficacy of pd-1 blockade, potentially through inhibition of myeloid-derived suppressor cells and cancer-associated fibroblasts.
Journal: Cancer immunology, immunotherapy : CII
Published: November 24, 2025
Successful treatment with tepotinib followed by pembrolizumab in pulmonary pleomorphic carcinoma harbouring a MET exon 14 skipping mutation: A case report.
Journal: Oncology letters
Published: September 25, 2025
Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501).
Journal: Cancers
Published: December 05, 2022
Micro- and Macro-Anatomical Frameworks of Lymph Nodes Indispensable for the Lymphatic System Filtering Function.
Journal: Frontiers in cell and developmental biology
Published: March 23, 2022
PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.
Journal: Cancer immunology, immunotherapy : CII
Published: March 20, 2021
Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity.
Journal: Scientific reports
Published: May 02, 2020
Aphthous lesions on the soft palate in a neonate.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: April 06, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026